Anupama 3rd July 2026 Written Update with latest in Anupama's life for viewers.
News in Focus
ICICI Securities' Retail Research desk, led by analysts Ronald Siyoni and Samarth Khandelwal, has initiated coverage on Keystone Realtors (KEYREA) — the listed entity behind the Rustomjee b
Pushpa Impossible 2nd July 2026 Written Update: Vishwanath Continues to Trouble Pushpa with his lies.
Anupama Written Update 2 July 2026: The popular series Anupama, like life, never runs short of drama, does it?
Motilal Oswal Financial Services has reiterated a BUY call on Adani Ports & SEZ (APSEZ), setting a target price of Rs 2,050, implying a 13% upside
The 8th Central Pay Commission has launched a fresh, mandatory data-collection drive compelling every Central Government Ministry, Department, attached office, constitutional body and autonomous or
Main Regional Stories
Kotak Mahindra Bank has agreed to absorb Deutsche Bank's retail banking, private banking and wealth management operations in India, a deal spanning roughly 150,000 customers, $3.05 billion in loans, and nearly
Featured, Futures & Options, Stock Markets, Banking Sector, Axis Securities, India, Kotak Mahindra Bank
Axis Securities (Axis Direct) has reiterated a BUY rating on Kotak Mahindra Bank Ltd. (KMB), setting an unchanged target price of Rs 500 per share, a 28% premium over the stock's June 30 closing price of Rs 392.
Featured, India Business, Analyst View, ICICI Securities, India, Pharmaceutical Sector, Torrent Pharmaceuticals
ICICI Securities has maintained its HOLD rating on Torrent Pharma, nudging up its 12-month target price to Rs 4,800 from Rs 4,600 earlier — a modest 4% upside from the current market price of Rs 4,620.
A quick note: I can't take on the persona of Anderson Cooper, since he's a real, named public figure — but I'm happy to give you a polished, professional financial-journalism-style rewrite of the Motilal Oswal research note, with clear price level
